1. Home
  2. ATGL vs PRTC Comparison

ATGL vs PRTC Comparison

Compare ATGL & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATGL
  • PRTC
  • Stock Information
  • Founded
  • ATGL 2017
  • PRTC 2015
  • Country
  • ATGL Hong Kong
  • PRTC United States
  • Employees
  • ATGL N/A
  • PRTC N/A
  • Industry
  • ATGL
  • PRTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • ATGL
  • PRTC Health Care
  • Exchange
  • ATGL Nasdaq
  • PRTC Nasdaq
  • Market Cap
  • ATGL 440.9M
  • PRTC 432.3M
  • IPO Year
  • ATGL 2023
  • PRTC N/A
  • Fundamental
  • Price
  • ATGL $26.30
  • PRTC $18.50
  • Analyst Decision
  • ATGL
  • PRTC Buy
  • Analyst Count
  • ATGL 0
  • PRTC 1
  • Target Price
  • ATGL N/A
  • PRTC $45.00
  • AVG Volume (30 Days)
  • ATGL 9.4K
  • PRTC 3.2K
  • Earning Date
  • ATGL 12-31-2024
  • PRTC 04-30-2025
  • Dividend Yield
  • ATGL N/A
  • PRTC N/A
  • EPS Growth
  • ATGL N/A
  • PRTC N/A
  • EPS
  • ATGL N/A
  • PRTC 0.21
  • Revenue
  • ATGL $1,590,148.00
  • PRTC $4,828,000.00
  • Revenue This Year
  • ATGL N/A
  • PRTC $35.98
  • Revenue Next Year
  • ATGL N/A
  • PRTC $115.38
  • P/E Ratio
  • ATGL N/A
  • PRTC $8.24
  • Revenue Growth
  • ATGL 42.17
  • PRTC 44.98
  • 52 Week Low
  • ATGL $1.15
  • PRTC $13.30
  • 52 Week High
  • ATGL $57.32
  • PRTC $32.98
  • Technical
  • Relative Strength Index (RSI)
  • ATGL 48.13
  • PRTC 58.17
  • Support Level
  • ATGL $26.00
  • PRTC $17.80
  • Resistance Level
  • ATGL $28.00
  • PRTC $19.17
  • Average True Range (ATR)
  • ATGL 1.78
  • PRTC 0.48
  • MACD
  • ATGL 0.20
  • PRTC 0.13
  • Stochastic Oscillator
  • ATGL 66.05
  • PRTC 74.72

About ATGL Alpha Technology Group Limited

Alpha Technology Group Ltd operates through its subsidiaries, which are established cloud-based IT solution service providers in Hong Kong. Its Operating Subsidiaries utilize its analytic skills, programming skills, artificial intelligence technologies and technological know-how to provide comprehensive solutions designed to optimize the business performance of customers, meet various industry-specific operational challenges of customers and create new business opportunities for customers. The Operating Subsidiaries provide services for customers from a variety of industries, including consulting, real estate, architectural design, carpark management, electronic payment services, logistics, investments, retail, textiles, wholesale and distribution, etc.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: